home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

Array BioPharma Inc.

SHARESHARESHARE
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
SHARESHARESHARE

RELATED NEWS


The phenomenal pace of the advancements in the overall pharmaceutical industry has had a positive impact on the global pharmaceutical packaging equipment market as well. Companies operating in the global market have brought in new technologies such as automation, which has leveraged the adoption of pharmaceutical packaging equipment amongst several small-scale manufacturers in many developing countries. The advancements have facilitated reliable processing and packaging of pharmaceuticals ensuri...
OPENPR.COM
READ MORE

The U.S. Food and Drug Administration on Tuesday approved a new generic of heart medicine Valsartan and said it prioritized the drug's review to help relieve recent shortage as manufacturers around the world have pulled the treatment from the market. Several drugmakers, including Teva Pharmaceutical Industries Ltd and Mylan NV, have recalled batches of Valsartan as the drugs have been found to contain probable carcinogens. The approval of the generic, Diovan, was granted to Alkem Laboratorie...

READ MORE

The European Commission (EC) has granted approval to Janssen‘s Daralex (daratumumab) for use in combination with lenalidomide and dexamethasone, or bortezomib (Velcade) and dexamethasone....

READ MORE

Most people would prefer to take a pill over an injection, and even an injection over an infusion. But not all drugs can be taken orally. In particular, this applies to most biologics, including insulin. Rani Therapeutics, based in San Jose, Calif., announced the first human trial of its RaniPill, which is designed to replace injections of biologics. The company had already performed more than 100 studies in animals to deliver drugs like insulin and Humira. The reason most biologics can’t ...

READ MORE

PCSK9 inhibitors, like Repatha (evolocumab) and Praluent (alirocumab), work by increasing the removal of low-density lipoprotein (LDL) or "bad" cholesterol from the blood. They have been shown to reduce LDL by 60 percent and decrease major cardiac events but cost much more than other cholesterol-lowering drugs with an average cost of $14,300 per year....

READ MORE

AstraZeneca’s immunotherapy Imfinzi has failed in another late stage study, while Roche’s rival Tecentriq combination has been approved in the sought-after first-line lung cancer indication. Cancer immunotherapies have produced some patchy trial results, and Imfinzi is no exception. This latest set of data from the phase 3 EAGLE study in advanced head and neck cancer showed Imfinzi (durvalumab) did not improve overall survival compared with standard chemotherapy. The failure comes af...

READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...